Martin A. Lehr - 17 Jan 2023 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role: Chief Executive Officer, Director
Signature: /s/ Alex Levit, Attorney-in-Fact
Issuer symbol: CNTX
Transactions as of: 17 Jan 2023
Net transactions value: +$4,995
Form type: 4
Filing time: 18 Jan 2023, 15:04:19 UTC
Previous filing: 19 Dec 2022
Next filing: 23 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNTX	Common Stock	Purchase	$4,995	+6,783	+5.5%	$0.7364	129,366	17 Jan 2023	Direct	F1, F2
holding	CNTX	Common Stock						820,190	17 Jan 2023	Martin Lehr 2000 Trust

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.
F2	The price reported above is a weighted average purchase price. These shares were acquired in several transactions at prices ranging from $0.7298 - $0.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Content

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.

The price reported above is a weighted average purchase price. These shares were acquired in several transactions at prices ranging from $0.7298 - $0.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.